Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Research Square
|
March 13, 2023
Mdm2/p53 levels in bone marrow mesenchymal stromal cells is essential for maintaining the hematopoietic niche in response to DNA damage
Rasoul Pourebrahim, Rafael Heinz Montoya, Zoe Alaniz, et al.
Cell Death & Disease
|
June 23, 2023
Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage
Rasoul Pourebrahim, Rafael Heinz Montoya, Zoe Alaniz, et al.
Cell Reports
|
August 18, 2021
Mds1<sup>CreERT2</sup>, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells
Yi Zhang, Kathleen E McGrath, Edward Ayoub, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Niche-level immune evasion in <i>TP53</i> mutant AML residual disease revealed by spatial proteomics
Hideaki Mizuno, Yuki Nishida, Andrea Bedoy, et al.
Nature Communications
|
October 14, 2018
EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
Edward Ayoub, Michael P Wilson, Kathleen E McGrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML
Bing Z Carter, Po Yee Mak, Suresh Satpati, et al.
Research Square
|
March 4, 2025
BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway
Amnon Peled, Michal Abraham, Hanna Wald, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 29, 2025
Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53
Li Li, Muharrem Muftuoglu, Edward Ayoub, et al.
Blood
|
December 8, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022
Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, et al.
Blood Cancer Journal
|
April 23, 2023
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Research Square
|
March 13, 2023
Mdm2/p53 levels in bone marrow mesenchymal stromal cells is essential for maintaining the hematopoietic niche in response to DNA damage
Rasoul Pourebrahim, Rafael Heinz Montoya, Zoe Alaniz, et al.
Cell Death & Disease
|
June 23, 2023
Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage
Rasoul Pourebrahim, Rafael Heinz Montoya, Zoe Alaniz, et al.
Cell Reports
|
August 18, 2021
Mds1<sup>CreERT2</sup>, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells
Yi Zhang, Kathleen E McGrath, Edward Ayoub, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Niche-level immune evasion in <i>TP53</i> mutant AML residual disease revealed by spatial proteomics
Hideaki Mizuno, Yuki Nishida, Andrea Bedoy, et al.
Nature Communications
|
October 14, 2018
EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription
Edward Ayoub, Michael P Wilson, Kathleen E McGrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML
Bing Z Carter, Po Yee Mak, Suresh Satpati, et al.
Research Square
|
March 4, 2025
BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway
Amnon Peled, Michal Abraham, Hanna Wald, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 29, 2025
Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53
Li Li, Muharrem Muftuoglu, Edward Ayoub, et al.
Blood
|
December 8, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022
Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, et al.
Blood Cancer Journal
|
April 23, 2023
Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Page
of 2